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 2 
Abstract 
In standard implementations of computational protein design, a positive-design approach is used 
to predict sequences that will be stable on a given backbone structure. Possible competing states 
are typically not considered, primarily because appropriate structural models are not available. 
One potential competing state, the domain-swapped dimer, is especially compelling because it is 
often nearly identical to its monomeric counterpart, differing by just a few mutations in a hinge 
region. Molecular dynamics (MD) simulations provide a computational method to sample 
different conformational states of a structure. Here, we tested whether MD simulations could be 
used as a post-design screening tool to identify sequence mutations leading to domain-swapped 
dimers. We hypothesized that a successful computationally-designed sequence would have 
backbone structure and dynamics characteristics similar to that of the input structure, and that in 
contrast, domain-swapped dimers would exhibit increased backbone flexibility and/or altered 
structure in the hinge-loop region to accommodate the large conformational change required for 
domain swapping. While attempting to engineer a homodimer from a 51 amino acid fragment of 
the monomeric protein engrailed homeodomain (ENH), we had instead generated a domain-
swapped dimer (ENH_DsD). MD simulations on these proteins showed increased MD 
simulation derived B factors in the hinge loop of the ENH_DsD domain-swapped dimer relative 
to monomeric ENH. Two point mutants of ENH_DsD designed to recover the monomeric fold 
were then tested with an MD simulation protocol. The MD simulations suggested that one of 
these mutants would adopt the target monomeric structure, which was subsequently confirmed 
by X-ray crystallography.  
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Introduction 
Computational protein design (CPD) provides in silico tools that facilitate the identification of 
amino acid sequences with desired properties. Most CPD algorithms sample an enormous 
number of amino acid types and side-chain conformations to find the most energy-favored 
sequences in the context of a single, fixed, backbone structure [1, 2]. Leveraging the speed of 
modern computers, CPD can effectively reduce the vast sequence space to an affordable number 
of sequences for experimental examination. CPD is particularly useful when combined with 
medium to high-throughput experimental screening and has led to successful designs for a 
variety of protein engineering problems [1, 3-10]. The utility of CPD, however, can be limited in 
applications where our understanding of the engineering problem is incomplete or an appropriate 
high-throughput experimental screening method does not exist. Another problem that can occur 
is that the designed sequence doesn’t fold into the desired structure but instead takes on the 
structure of a competing state, including unfolded or aggregated states. For example, Fleishman 
et al. [5] recently showed that only 2 of 88 CPD-designed variants from different protein 
scaffolds bound to the target molecule, influenza hemagglutinin. A community-wide assessment 
of this study suggested that many of the failed designs do not adopt the target fold [11]. In 
addition, only half express solubly [12], likely due to poor stability. The ability to predict 
whether a designed protein sequence will be correctly folded and stable prior to evaluating it 
experimentally would be extremely beneficial, as it would filter out “poor sequences” so that 
time-consuming and expensive experimental validations need only be done on sequences that are 
more likely to have the desired properties. 
Although the conformational population of a protein depends on the relative energetic 
contributions of all possible states, most CPD methods evaluate designed sequences based on 
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 4 
only one desired state. Consequently, even though the sequences obtained from these single-state 
designs may have acceptable CPD scores, this does not ensure that the desired fold dominates the 
population because the designed sequences may have better scores on structures other than the 
target state. Unfortunately, explicitly modeling alternative states is challenging because the 
structure of these states are typically unknown.  
The stability, specificity, and activity of a protein often depend not only on the protein’s 
structure but also on its dynamic properties. Protein variants with altered dynamics may lead to 
undesired outcomes such as amyloidogenesis [13, 14]. The goal of many protein engineering 
projects is therefore to maintain the basic structure and dynamics of the protein while improving 
a desired property (e.g., catalytic activity [15], thermostability [16], substrate specificity [17], 
ligand binding [18], and molecular transport [19]). However, protein dynamics is typically not 
directly modeled in CPD calculations. Molecular dynamics (MD) simulations provide a powerful 
tool for exploring local conformational ensembles of the native state and thus provide an 
opportunity to improve CPD by including an aspect of protein dynamics in the design process. 
Indeed, Allen et al. showed that MD generated structure ensembles could be successfully used 
for computational multi-state protein design [20].  
MD simulations can also serve as a complementary tool to evaluate the dynamic properties 
of CPD-generated proteins. Both Kiss et al. [21] and Privett et al. [22] used MD simulations as a 
post-design screening method in the de novo design of an enzyme to catalyze the Kemp 
elimination reaction. In these studies, the dynamics of the substrate in the designed active site 
was monitored using MD. The population of competing states (i.e., substrate bound vs. substrate 
free) was calculated in the MD trajectories of putative enzyme variants and used as a filter to 
identify those likely to exhibit Kemp elimination activity. This approach proved successful and 
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 5 
led to the development of a catalytically efficient computationally designed enzyme for the 
Kemp elimination [22] that was further optimized through directed evolution to yield an enzyme 
with kinetic parameters comparable to naturally evolved enzymes [15]. In addition, MD 
simulations have also been used to investigate the mechanisms of enzyme catalysis [23, 24]. 
Among the competing alternate structural states of proteins, domain-swapped dimers are 
common because they are often nearly structurally identical to their monomeric counterparts [25]. 
Altering one or two amino acids in a hinge-loop region can promote the conformational change 
needed for domain-swapped dimerization while keeping the rest of the protein structurally 
unchanged. Studies have shown that mutating these critical residues can significantly affect 
domain-swapping tendency [26, 27].  
Given that domain-swapped dimer structures are usually not explicitly modeled in CPD 
calculations, it is not surprising that designed sequences that could assume these folds would be 
among those predicted, especially if the design involves alteration of loop residues. For example, 
O’Neill et al. used CPD to design the IgG-binding domain of protein L and found that one of the 
point mutants (G55A) led to a weak domain-swapped dimer with a dissociation constant (Kd) of 
~30 μM [26] that was further stabilized by two additional mutations (A52V and D53P) resulting 
in an obligate domain-swapped dimer with a Kd of ~0.7 nM [27]. Similarly, while attempting to 
design a homodimer from a 51 amino acid fragment of the monomeric protein engrailed 
homeodomain (ENH), we generated a high affinity dimer, ENH_DsD (Table S1), with a Kd of 
~40 nM that also proved to be domain-swapped when examined by X-ray crystallography. 
Comparison of the crystal structures of ENH and the domain-swapped dimer, ENH_DsD, 
suggested that domain swapping might be accommodated by opening of a putative hinge loop 
between the first and second helices. We hypothesized that ENH_DsD’s ability to form a 
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 6 
domain-swapped dimer would be revealed in higher backbone flexibility and/or altered local 
structure along this hinge loop in the corresponding monomeric state, and that the wild-type 
protein (ENH), which does not adopt a domain-swapped structure, would have lower flexibility 
and stably adopt the structure in this loop. We anticipated that these differences in loop 
flexibility and/or structure might be observable in MD simulations of the two proteins and set out 
to explore this possibility. As anticipated, short 20 ns MD simulations revealed greater flexibility 
in the hinge loop for ENH_DsD than for wild-type ENH (although the gross structure in the 
hinge-loop region remained essentially the same). Similarly, we reasoned that mutations to 
ENH_DsD that caused the protein to revert to the native ENH fold would also show wild-type-
like hinge-loop flexibility and structure. This proved to be the case – an ENH_DsD point mutant 
that showed wild-type-like hinge-loop flexibility and structure was confirmed by X-ray 
crystallography to assume the wild-type native fold. To assess the general applicability of this 
MD simulation protocol, we also investigated domain-swapped oligomer variants of the IgG-
binding domain of protein L and the IgG-binding domain of protein G and found that their hinge-
loop properties correlated with the strength of domain-swapped oligomerization. 
Results and Discussion 
De Novo Homodimer Design Produced the Domain-Swapped Dimer ENH_DsD. Our 
original goal was to use computational tools to engineer a de novo homodimer from a 
monomeric protein. We docked 51 amino acid fragments of two Drosophila melanogaster 
engrailed homeodomain monomers (PDB ID: 1ENH) [28] in silico to form a C2-symmetric 
homodimer [29] then used CPD to redesign the formed protein-protein interface in order to 
create affinity between the two identical chains. The oligomeric state(s) of the designed variants 
was determined using size exclusion chromatography and fluorescence polarization techniques. 
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To assist in these assays, a yellow fluorescent protein (YFP) [30] was fused to the C terminus of 
each of the designed sequences. Size exclusion chromatography revealed that one of the 
designed sequences, ENH_DsD, elutes primarily as a dimer (Fig. 1A). Fluorescence polarization 
was determined using a Förster resonance energy transfer (FRET) assay, which yielded a Kd of 
~40 nM (Fig. 1B). The decreased polarization at higher concentrations is caused by the 
dimerization of ENH_DsD-YFP in which two nearby YFPs transfer energy to each other (homo-
FRET). Note that these assays cannot distinguish between the target dimer configuration (where 
each chain retains the native ENH fold) and a domain-swapped dimer. X-ray crystallography was 
used to determine the detailed molecular architecture of ENH_DsD-YFP, resulting in a structure 
at 1.9 Å resolution (Fig. 2A; Table S2). Analysis revealed a domain-swapped dimer formed 
between two ENH_DsD sequences (Fig. 2B). In the domain-swapped structure, the first helix, 
the hinge loop, and the second helix form a single extended helix such that the first helix on one 
chain interacts with the second and third helices on the second chain (Fig. 2C). The rest of the 
structure essentially remains intact; excluding the hinge-loop region, superposition of ENH_DsD 
and wild-type ENH gives a Cα RMSD of 0.6 Å (Fig. 2B). Note that ENH_DsD shares only 49% 
sequence identity with wild-type ENH (25 out of 51 residues). To reduce the concern that the 
YFP fusion may play a role in causing the domain-swapping, we also solved the X-ray crystal 
structure of a closely related variant that lacks the YFP fusion and found that it also forms a 
domain-swapped dimer structure similar to ENH_DsD (Fig. S1 and Table S4). 
Molecular Dynamics Simulations Suggest Increased Hinge-Loop B Factors are Associated 
with ENH_DsD Domain-Swapping. We hypothesized that flexibility and/or altered structure in 
the hinge-loop region could be observed with B factors computed from MD simulation, and that 
the B factors of the ENH_DsD sequence threaded onto the ENH native structure would show 
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high flexibility for the hinge-loop region relative to wild-type ENH. We ran multiple 20 ns MD 
simulations on wild-type ENH and on the ENH_DsD sequence threaded onto the native ENH 
structure, and for each trajectory, calculated the backbone root mean square fluctuation (rmsf) 
for each Cα over the entire trajectory and converted these values to B factors. Three trajectories 
were run for each sequence and the average B factors were calculated and used as a measure of 
both altered structure and structural flexibility. As seen in Fig. 3A, nearly all the residues in wild-
type ENH have low computed B factors with the exception of residues close to the N and C 
termini. The B factors for the ENH_DsD sequence threaded onto the native ENH structure (Fig. 
3B) are generally larger than those of ENH – the average B factor for residues 4 through 48 are 
17 Å
2
 and 27 Å
2
 for ENH and ENH_DsD, respectively (Table 1). Notably ENH_DsD residue 24 
in the hinge-loop region has a B factor more than three times larger than the equivalent position 
in ENH, supporting the hypothesis that higher B factors in the hinge-loop region is associated 
with domain swapping. 
ENH_DsD Mutant Designed to Recover Native Fold Reverts to Wild-Type Hinge-Loop 
Flexibility. Introduction of proline in the hinge-loop region was pursued as an approach to break 
the extended helical secondary structure seen in the ENH_DsD X-ray structure (Fig. 2A) and to 
recover the native ENH fold. Steric interference from the pyrrolidine ring in proline precludes 
the residue directly N-terminal to proline from adopting a helical structure. In addition, since 
prolines often occupy the first or second position of -helices [31], we substituted a proline into 
position 23 (E23P) and separately position 24 (E24P) of ENH_DsD and examined the B factors 
of these variants using the MD simulation protocol described above. As can be seen in Fig. 3C 
for the E23P variant, the average of the B factors for the non-terminal residue positions for E23P, 
18 Å
2
, is nearly identical to wild-type ENH, 17 Å
2
, and well below that of ENH_DsD at 27 Å
2
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 9 
(Table 1). Moreover, the maximum B factor value in the hinge-loop region of E23P, 33 Å
2
, is 
almost half that of ENH_DsD, 71 Å
2
, and approaches that of wild-type ENH, 21 Å
2
 (Table 1). In 
contrast, E24P (Fig. 3D) has characteristics that resemble ENH_DsD: the average overall B 
factor, 35 Å
2
, is nearly twice that of wild-type ENH; and, the maximum hinge-loop B factor, 107 
Å
2
, is more than five times that of wild-type ENH (Table 1). These results suggest that the E23P 
sequence is stable in the ENH native fold and less likely to fold to an alternative structure, while 
the E24P is less stable in the ENH native fold and more likely to adopt an alternative fold in a 
manner similar to ENH_DsD. 
We also performed 100-ns MD simulations on the ENH variants, which show trends 
qualitatively similar to the 20-ns simulations but are less distinctive (Fig. S2). For example, the 
B-factor enhancement of E24P at the hinge loop, while still apparent, is less obvious compared 
to the 20-ns simulation (Fig. 3D). A longer MD simulation might relax the structure more and 
find alternative conformations with less flexibility. The crystallographic input structure is clearly 
important for the MD protocol ─ the later time windows appear to lose important information 
present in the starting structures. 
Biophysical Analyses Support MD Simulation Predictions. We constructed the E23P-YFP 
and E24P-YFP proteins and examined their dimerization properties using a homo-FRET assay. 
E23P-YFP forms a tight dimer with a Kd of ~10 nM (Fig. S3). However, E24P-YFP expresses 
poorly and shows no detectable dimerization at concentrations as high as 5 μM (anisotropy >300 
mA; data not shown).  
To explore the MD simulation suggestion that E23P is a regular dimer and not a domain-
swapped dimer, we determined the X-ray crystal structure of E23P-YFP to 2.3 Å resolution (Fig. 
4A and Table S3). Superposition of the wild-type ENH and E23P-YFP structures (Fig. 4B) shows 
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that the single proline mutation at position 23 rescues the native fold. The Cα RMSD for E23P vs. 
ENH is 0.4 Å for all backbone atoms and 0.6 Å for the backbone atoms in the hinge-loop region. 
The X-ray structure thus confirms that the dimerization observed by homo-FRET results from a 
regular dimer (as opposed to a domain-swapped dimer). Notably, the dimer that is formed does 
not match the intended CPD homodimer design target (Fig. S4). Instead of a single four-helix 
bundle interface formed by association of the designed surfaces on the second and third helices, 
two interfaces are formed between each of the designed surfaces and a patch on YFP (Fig. 4A). 
This finding emphasizes the challenge of avoiding unwanted structural states in CPD and 
highlights the need for improved negative design approaches. 
Protein L and Protein G Variants Test Applicability of MD Simulation Protocol. We also 
investigated variants of the B1 domain of protein L from Peptostreptococcus magnus generated 
by Baker and coworkers [26, 27] and variants of the B1 domain of streptococcal protein G 
generated by Gronenborn and coworkers [32, 33]. O’Neill et al. showed that the point mutant 
G55A of protein L is a weak domain-swapped dimer with a Kd of ~30 μM [26]. Kuhlman et al. 
used CPD to identify mutations that stabilize the domain-swapped dimer structure while 
destabilizing the monomer structure, creating a triple mutant (A52V/N53P/G55A) obligate dimer 
with a Kd of ~700 pM [27]. The proline substitution at position 53 is not compatible with the 
structure of the monomer and is expected, at a minimum, to alter the local structure. In protein G, 
Frank et al. showed that a quintuple mutant (L5V/A26F/F30V/Y33F/A34F) forms an intertwined 
tetramer [32]. Byeon et al. subsequently showed that the quadruple mutant (lacking the A26F 
mutation) forms a domain-swapping dimer [33]. We applied the MD simulation method 
described above to three protein L sequences (wild type, G55A, and the triple mutant) and three 
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protein G sequences (wild type, the quadruple mutant, and the quintuple mutant) to evaluate 
whether the B factors of the hinge loop reflects the proteins’ domain-swapping tendencies.  
The two protein L and two protein G variant sequences were threaded onto their 
respective wild-type native monomeric structures (PDB IDs: 1HZ5 and 1PGB) [34] and the MD 
simulation protocol was applied. The torsion-angle strain caused by the N53P mutation in the 
protein L monomer structure was fully relaxed by energy minimization at the initial stage of the 
MD simulation protocol. Compared to wild-type ENH, wild-type protein L has larger B factors 
in the hinge-loop region (Fig. 5A) with a maximum B factor in that region almost four times that 
of ENH (Table 1), which emphasizes that relative B factors within a series of related variants 
will be more important than the absolute B factors of any individual protein. As can be seen in 
Fig. 5B, the hinge-loop B factors of G55A are reduced relative to wild-type protein L, suggesting 
that the MD simulation protocol is not able to detect variants that are only weakly domain-
swapped. In contrast, the obligate domain-swapped dimer triple mutant shows a significant 
increase in hinge-loop B factors relative to wild-type protein L (Fig. 5C) with a maximum hinge-
loop B factor greater than two times that of protein L (Table 1). Note that in addition to the 
hinge-loop region (residues 51-56), residues 41-45 of this triple mutant also display enhanced B 
factors compared to wild-type protein L. This points out a limitation of the MD protocol. 
Although the protocol can predict domain swapping, it may not unambiguously identify the 
hinge-loop region and thus require additional information in order to focus on the relevant 
protein segment. 
In the case of protein G, the quadruple and the quintuple mutants show approximately 
two-fold and four-fold increases in the maximum hinge-loop B factor (at position 38) compared 
to wild-type protein G, respectively (Fig. 5D, 5E, 5F and Table 1). Note that although the 
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quadruple mutant of protein G is a weak domain-swapped dimer with a Kd (~93 μM) similar to 
that of the G55A mutant of protein L (~30 μM), the MD simulation protocol can only identify 
the B factor increase for the protein G case. This might be explained by the extent of the 
mutations. The G55A mutant of protein L only changes the structure by a single methyl group, 
while the mutations introduced in the quadruple mutant of protein G are much more extensive 
(L5V/F30V/Y33F/A34F), suggesting that the G55A mutation might be too subtle for the MD 
simulation protocol used in this study. 
Direct Computation of Monomer and Domain-Swapped Oligomer Stability. The availability 
of both monomeric and domain-swapped oligomer structures for ENH, protein L, and protein G 
variants allows the direct computation of CPD energies for the various sequences threaded onto 
different structural states. Table 1 summarizes the computed monomer and domain-swapped 
oligomer energies for the three protein series. With the exception of the E24P ENH variant, the 
monomer/domain-swapped oligomer fold preferences derived from computed stability match the 
MD simulation flexibility trends that are based on the monomer structure alone. The MD 
simulation results for the E24P variant suggest that the sequence is not stable on the native 
monomer fold, while the computed stabilities clearly indicate a preference for the native 
monomer fold over the domain-swapped dimer fold. Experimentally, the E24P variant is poorly 
behaved and shows no sign of dimer formation at concentrations as high as 5 μM (data not 
shown). Both the B factor analysis and CPD energy analysis incorrectly predict the behavior of 
the weakly dimeric G55A protein L variant (Kd of ~30 μM). However, the difference in 
computed monomer/dimer energies for wild-type protein L and the G55A variant, 32 and 8 
Rosetta units, respectively, suggest that the G55A variant is less stable on the native monomer 
fold and more stable on the domain-swapped dimer fold relative to wild-type protein L. Overall, 
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in the absence of explicit models for alternative structural states, MD simulation based B factor 
analysis appears to be a good surrogate for predicting the domain-swapping behavior of CPD-
derived amino acid sequences. 
MD Simulation as a Post-CPD Screening Method. MD simulations can serve as a complement 
to CPD by mitigating common method limitations such as the use of discrete side-chain rotamers, 
fixed protein backbone, and absence of explicit water. The continuous structure space of MD 
simulations allows for a much more accurate description of protein “softness.” The explicit 
inclusion of water is also a key feature for accurate protein modeling, especially for 
surface/pocket designs, loop designs, binder designs, and enzyme designs. Several groups have 
thus used MD simulations as a post-CPD filter for various engineering applications. For example, 
Kiss et al. [21] used MD simulations to evaluate and re-rank variants obtained from de novo 
enzyme designs for the Kemp elimination reaction. Active designs could be clearly distinguished 
from inactive ones in 20 of the 23 cases tested, a significant improvement over the success rate 
of CPD alone, which had 8 active out of 59 tested designs [3]. Privett et al. used a similar MD 
simulation protocol to suggest a point mutant that resulted in a 3-fold improvement in Kemp 
elimination activity [22]. 
Liang et al. also reported studies in which MD simulations were used to validate designs 
[35]. They showed that the stability of a designed complex containing a computationally-grafted 
binding epitope could be evaluated by MD simulation. Although their root means square (rms) 
analysis requires a much longer MD simulation time (~400 ns), it is conceptually similar to our 
rmsf B factor protocol. The Liang et al. study emphasized the importance of protein dynamics—
whereas MD analysis was able to distinguish stable protein complexes from unstable ones, 
monomer-dimer ΔG values calculated from static structures could not.  
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Conclusions 
We presented a simple MD simulation protocol for evaluating the domain-swapping tendency of 
CPD-designed protein variants. The protocol consists of a 20 ns MD simulation of the designed 
sequence followed by rmsf analyses to generate B factors for backbone atoms. Applying this 
protocol to the domain-swapped dimer ENH_DsD, we found higher B factors in the hinge-loop 
compared to that of the monomeric wild-type protein. To recover the wild-type fold, two mutants, 
E23P and E24P, were made and examined using the MD simulation protocol. E23P exhibited 
wild-type-like backbone B factors and was therefore predicted to revert to the wild-type fold. 
Determination of the structure by X-ray crystallography confirmed the MD simulation prediction. 
We tested the applicability of our method on variants of protein L and protein G and similarly 
found that domain-swapping tendency correlated with elevated B factors in the hinge region. We 
anticipate that our MD protocol can be used as an in silico post-CPD filter, which may 
circumvent the need for time-consuming structural studies and may be most useful when 
experimental screening techniques are not adequate.  
Materials and Methods 
Construct Preparation, Expression, and Purification. Oligonucleotides (Integrated DNA 
Technologies) containing ~20 bp overlapping segments were assembled via a modified Stemmer 
polymerase chain reaction (PCR) method using KOD Hot Start Polymerase (Novagen) to 
generate the full-length designed sequence ENH_DsD (Table S1). The PCR product and YFP 
gene [30] with a C-terminal His6 tag at the 3 end were fused using overlap extension PCR. The 
ENH_DsD-YFP gene was then cloned into pET-11a using standard digestion/ligation methods. 
The E23P and E24P mutants were created by standard Quikchange protocols. The plasmids were 
transformed into Escherichia coli BL21(DE3) cells; colonies were picked, and the plasmids 
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mini-prepped and sequenced. Sequence-verified constructs were expressed in standard Luria 
Broth at 37 
º
C using 1 mM isopropyl β-D-1-thiogalactopyanoside (IPTG) for 3 h. The cells were 
centrifuge harvested, sonication lysed, and Ni
2+
-NTA (Qiagen) purified. 
Size-Exclusion Chromatography. Size-exclusion chromatography was carried out at room 
temperature using an analytical Superdex-75 column (Amersham Pharmacia). After affinity 
column purification, each sample was loaded on an ÄKTA FPLC system with 0.5 mL sample 
volume and run at 0.5 mL/min flow rate with running buffer (100 mM NaCl and 20 mM Tris-
HCl, pH 8.0). Absorbance at 520 nm was tracked for protein elution. Typically >10 mg protein/L 
cell culture was purified for each construct. 
Fluorescence Polarization Assay. The fluorescence polarization was measured at room 
temperature with a Fluorolog-3 spectrofluorometer (HORIBA). ENH_DsD-YFP was serially 
diluted in buffer containing 100 mM NaCl and 20 mM TrisHCl at pH 8.0. The fluorescence 
anisotropy was measured for each sample and the G-factor was determined individually. The 
data were analyzed according to a simple monomer-dimer equilibrium model and fit with 
KaleidaGraph software. The anisotropy values (mA) for the completely monomeric and dimeric 
states were fit to be 330 and 260, respectively.  
Crystallography. The ENH_DsD-YFP crystals were grown in 0.8 M monosodium phosphate, 
1.2 M dipotassium phosphate, and 0.1 M sodium acetate at pH 4.5 using hanging-drop diffusion. 
The E23P-YFP crystals were grown in 0.1 M sodium chloride, 0.1 M 12% v/v/ 2-propanol, 0.1 
M sodium acetate at pH 4.6 using hanging-drop diffusion. The Crystals were flash frozen in 
glycerol cryo-protectant and shipped to beamline 12-2 at Stanford Synchrotron Radiation 
Lightsource. Phases were obtained through molecular replacement using YFP as a model (PDB: 
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1MYW) [30]. Following molecular replacement, the ENH_DsD and E23P residues were built 
manually into the electron density maps using COOT [36]. Further refinement was performed 
using PHENIX [37]. Final coordinates were deposited in the Protein Data Bank with the codes 
4NDJ for ENH_DsD-YFP and 4NDK for E23P-YFP. Data collection and refinement statistics 
are listed in Tables S2 and S3. 
 
MD Simulations. The input structures for the MD simulations were prepared as follows. 1ENH, 
1HZ5, and 1PGB were used as the template backbone structures for the engrailed homeodomain, 
IgG-binding domain of protein L, and IgG-binding domain of protein G sequences, respectively. 
The TRIAD computational protein design software was used for creating the mutant atomic 
coordinates. Sequences were first threaded onto the corresponding backbone structure and side-
chain repacking optimization was applied on the full sequence. An improved version of FASTER 
was used for the side-chain repacking optimization [38] with a rotamer library based on the 
backbone-dependent library of Dunbrack and Karplus [39] and the ROSETTA scoring function 
[40]. The structures were then input to GROMACS 4.5.5 for energy minimization (GROMOS 
43a1) with an explicit water box under periodic boundary conditions [41]. Charge neutrality was 
achieved by adding sodium or chloride ions. After energy minimization converged to Fmax < 
1000 kJ/mol, a 20 ps position-restrained MD simulation was run for water relaxation at 300 K 
with 2 fs steps. Finally, a 20 ns unrestrained MD was run at 300 K under NPT conditions. The 
rmsf of Cα atoms was analyzed by g_rmsf built in GROMACS for the later 20 ns trajectory. A 
total of three trajectories initiated with different random seeds were run for each sequence and 
the averaged B factors ware calculated using the following equation: B = (8π2/3) × (rmsf)2, 
where the rmsf units are Å. 
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ACCESSION NUMBERS: Coordinates and structure factors have been deposited in the Protein 
Data Bank with accession number 4NDJ, 4NDK and 4ZN8. 
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Figure Legends 
Fig. 1. (A) Size-exclusion chromatography for ENH_DsD-YFP (black) and a monomeric control, 
UVF-YFP (gray). UVF is a computationally designed 39-fold mutant of ENH whose NMR 
solution structure matches the wild-type (monomeric) fold [42]. (B) Fluorescence polarization of 
ENH_DsD-YFP. 
Fig. 2. (A) X-ray crystal structure of ENH_DsD-YFP resolved to 1.9 Å. The two chains in 
ENH_DsD are shown in green and cyan and the YFP sequences are shown in gray. (B) 
Superposition of ENH_DsD portion of ENH_DsD-YFP with wild-type ENH structure (PDB ID: 
1ENH) (gray). (C) The hinge loop rearrangement (arrow) between the first and second helices in 
the wild-type ENH structure (gray) and ENH_DsD-YFP (cyan). This change leads to an ~180º 
rearrangement of helix 2 such that helix 1, the hinge, and helix 2 form a single long helix in 
ENH_DsD. 
Fig. 3. MD simulation-based B factor analyses for wild-type ENH (A), ENH_DsD (B), E23P (C), 
and E24P (D). Hinge residues are indicated with a gray bar in each panel. 
Fig. 4. (A) X-ray crystal structure of E23P-YFP resolved to 2.3 Å. The E23P sequence is shown 
in green and cyan for each of the two chains and the YFP sequences are shown in gray. (B) 
Superposition of E23P portion of E23P-YFP with the wild-type ENH structure (gray). 
Fig. 5. MD simulation-based B factor analyses for protein L and protein G variants. (A) Wild-
type protein L. (B) protein L single mutant G55A. (C) Protein L triple mutant A52V/D53P/G55A. 
(D) Wild-type protein G. (E) Protein G quadruple mutant L5V/F30V/Y33F/A34F. (F) Protein G 
Quintuple mutant L5V/A26F/F30V/Y33F/A34F. Hinge residues are indicated with a gray bar in 
each panel. 
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Table 1. Comparison of MD-derived hinge-loop B factors with domain swapping, Kd values, 
and CPD energies for ENH, protein L, and protein G variants. 
  
 
Domain 
swappe
d 
 
 
 
Kd
* 
(nM)
 
 
Average 
Protein 
B-factor 
(Å
2
)
†
 
 
Maximu
m 
hinge-
loop 
B-factor 
(Å
2
)
‡
 
 
 
 
Monome
r 
CPD 
energy 
(Rosetta 
units) 
Domain-
swapped 
oligomer 
CPD 
energy 
(Rosetta 
units)
§ 
ENH (WT) No n/a 17.
4 
21.1 -
127.
0 
-
115.
7 
ENH_DsD Yes 40  27.
4 
70.9 -
125.
2 
-
141.
8 
E23P No 10 18.
4 
32.7 -
123.
7 
160.
8 E24P n/a n/a 35.
4 
106.
6 
-
120.
6 
104.
5 Protein L (WT) No n/a 27.
8 
78.4 -
183.
1 
-
151.
9 
G55A Yes 30,00
0  
21.
0 
58.2 -
166.
2 
-
158.
5 
A52V/D53P/G55A Yes 0.700  34.
0 
179.
6 
249.
1 
-
172.
4 
Protein G (WT) No n/a 14.
6 
21.9 -
106.
4 
-
78.3 L5V/F30V/Y33F/A34F Yes 93,00
0  
19.
5 
41.8 -
75.5 
-
85.2 L5V/A26F/F30V/Y33F/A3
4F 
Yes n/a  29.
1 
86.6 -8.1 -
47.4  
*
Dissociation constant for dimer if applicable. 
§
The domain-swapped dimer or tetramer energy divided by two or four for comparison with the 
monomer energy. 
†
Average B factors for residues 4 through 48, 4 through 61, and 4 through 53 for ENH, protein L, 
and protein G variants, respectively. 
‡
Maximum B factors for residues 24, 53, and 38 for ENH, protein L, and protein G variants, 
respectively. 
 
 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 26 
 
Figure 1 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 27 
 
Figure 2 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 28 
 
Figure 3 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 29 
 
Figure 4 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 30 
 
Figure 5 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 31 
 
 
Graphical abstract 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 32 
Highlights 
 CPD calculations that do not consider competing states may lead to off-target folding. 
 We developed a MD simulation protocol as a post-CPD screening tool. 
 The MD protocol identifies mutations leading to undesired competing states. 
 The MD protocol predicts mutations that favor the target fold.  
 CPD combined with MD screening can greatly improve design success rates. 
